ProteoNic Announces Licensing of Its Premium 2G UNic™ Technology Platform for Production of Biologics to FyoniBio
FyoniBio has signed a licensing agreement with ProteoNic, gaining global, non-exclusive rights to integrate the premium 2G UNic™ expression technology into its proprietary CHOnamite® platform. This collaboration will expand cell line development options and help reduce production costs for FyoniBio’s clients, especially for complex or hard-to-produce biologics.
